PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Oncology, Göttingen Center of Molecular Biosciences (GZMB), University Medical Center Göttingen, Germany.\', \'NGS Integrative Genomics Core Unit, Institute of Human Genetics, University Medical Center Göttingen, Germany.\', \'Institute of Medical Microbiology, Göttingen Center of Molecular Biosciences (GZMB), University Medical Center Göttingen, Germany.\', \'Department of Molecular and Medical Virology, Ruhr University Bochum, Germany.\', \'Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.\', \'Institute of Human Genetics, University Medical Center Göttingen, Germany.\', \'Institute of Molecular Oncology, Göttingen Center of Molecular Biosciences (GZMB), University Medical Center Göttingen, Germany. Electronic address: mdobbel@uni-goettingen.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0168-1702(21)00176-310.1016/j.virusres.2021.198469
?:doi
?:hasPublicationType
?:journal
  • Virus research
is ?:pmid of
?:pmid
?:pmid
  • 34090962
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.147
?:rankingScore_hIndex
  • 102
is ?:relation_isRelatedTo_publication of
?:title
  • The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all